SOLUBILIZATION OF GLIBENCLAMIDE WITH BETA-CYCLODEXTRIN AND ITS DERIVATIVES

被引:18
作者
SANGHAVI, NM
VENKATESH, H
TANDEL, V
机构
[1] Pharmaceutical Section University, Department Of Chemical Technology Matunga, Bombay
关键词
D O I
10.3109/03639049409038367
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Glibenclamide, a widely used potent hypoglycaemic agent was solubilized using beta -Cyclodextrin and beta -Cyclodextrin derivatives. Complexes were prepared by kneading method in a molar ratio of 1:1 of the drug and the cyclodextrins respectively. The Glibenclamide beta-Cyclocextrin complex was characterized and evaluated by I.R. studies, Differential Scanning Calorimetry & X-ray diffractometry. The in-vitro dissolution rates of drug from inclusion complexes of beta - Cyclodextrins and its derivatives were compared. A significant improvement in dissolution rates of Glibenclamide was observed with inclusion complexes of all the Cyclodextrins. However, the solubilizing effect was more in case of beta-Cyclodextrin derivatives.
引用
收藏
页码:1275 / 1283
页数:9
相关论文
共 10 条
[1]  
CHRIST OE, 1969, HORMONE METABOLIC S, V1, P51
[2]   MECHANISM OF DRUG DISSOLUTION RATE ENHANCEMENT FROM BETA-CYCLODEXTRIN-DRUG SYSTEMS [J].
CORRIGAN, OI ;
STANLEY, CT .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (10) :621-626
[3]   A STUDY OF THE INCLUSION COMPLEX OF NAPROXEN WITH BETA-CYCLODEXTRIN [J].
ERDEN, N ;
CELEBI, N .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 48 (1-3) :83-89
[4]  
Higuchi T., 1965, PHASE SOLUBILITY TEC, V4, P117
[5]  
MARCUS E, 1989, J PARENTER SCI TECHN, V43, P5
[6]   A STUDY OF THE INCLUSION COMPLEX OF AMPHOTERICIN-B WITH GAMMA-CYCLODEXTRIN [J].
RAJAGOPALAN, N ;
CHEN, SC ;
CHOW, WS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 29 (2-3) :161-168
[7]  
SANGHAVL NM, IN PRESS DRUG DEV IN
[8]  
SEO H, 1983, CHEM PHARM BULL, V31, P286
[9]   IMPROVEMENT OF DISSOLUTION AND ABSORPTION CHARACTERISTICS OF BENZODIAZEPINES BY CYCLODEXTRIN COMPLEXATION [J].
UEKAMA, K ;
NARISAWA, S ;
HIRAYAMA, F ;
OTAGIRI, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1983, 16 (03) :327-338
[10]  
Uekama K., 1990, DRUG INVEST S4, V2, P22